Alliancebernstein L.P. Regeneron Pharmaceuticals, Inc. Transaction History

Alliancebernstein L.P.

$275 Billion
Q1 2024

A detailed history of Alliancebernstein L.P. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 736,533 shares of REGN stock, worth $774 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

736,533

Previous 744,217 1.03%

Holding current value

$774 Million

Previous $654 Million 8.46%

% of portfolio

0.26%

Previous 0.26%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$902.69 - $993.35 $6.94 Million - $7.63 Million	-7,684 Reduced 1.03%	736,533 $709 Million
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $40.3 Million - $45.8 Million	51,959 Added 7.51%	744,217 $654 Million
Q3 2023 Nov 14, 2023	BUY	$692.45 - $844.37 $3.05 Million - $3.71 Million	4,399 Added 0.64%	692,258 $570 Million
Q2 2023 Aug 15, 2023	BUY	$700.03 - $830.35 $52.5 Million - $62.3 Million	74,973 Added 12.23%	687,859 $494 Million
Q1 2023 May 15, 2023	BUY	$680.49 - $826.97 $5.25 Million - $6.37 Million	7,708 Added 1.27%	612,886 $504 Million

Q4 2022 Feb 14, 2023	SELL	$705.89 - $766.39 $34 Million - $36.9 Million	-48,195 Reduced 7.38%	605,178 $437 Million
Q3 2022 Nov 15, 2022	SELL	$573.97 - $724.32 $385,707 - $486,743	-672 Reduced 0.1%	653,373 $450 Million
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $41.8 Million - $56.3 Million	76,176 Added 13.18%	654,045 $387 Million
Q1 2022 May 13, 2022	BUY	$595.12 - $698.43 $4.61 Million - $5.41 Million	7,749 Added 1.36%	577,869 $404 Million
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $37.2 Million - $45.9 Million	68,434 Added 13.64%	570,120 $360 Million
Q3 2021 Nov 10, 2021	SELL	$574.03 - $680.96 $217 Million - $258 Million	-378,465 Reduced 43.0%	501,686 $304 Million
Q2 2021 Jul 30, 2021	SELL	$472.8 - $558.54 $566 Million - $669 Million	-1,197,100 Reduced 57.63%	880,151 $492 Million
Q1 2021 May 06, 2021	BUY	$446.73 - $548.2 $140 Million - $172 Million	313,907 Added 17.8%	2,077,251 $983 Million
Q4 2020 Feb 08, 2021	BUY	$478.3 - $607.98 $99.9 Million - $127 Million	208,936 Added 13.44%	1,763,344 $852 Million
Q3 2020 Nov 12, 2020	BUY	$544.75 - $658.21 $6.35 Million - $7.68 Million	11,662 Added 0.76%	1,554,408 $870 Million
Q2 2020 Aug 13, 2020	SELL	$493.32 - $643.92 $139 Million - $181 Million	-281,790 Reduced 15.44%	1,542,746 $962 Million
Q1 2020 May 14, 2020	SELL	$336.18 - $494.43 $43 Million - $63.3 Million	-128,021 Reduced 6.56%	1,824,536 $891 Million
Q4 2019 Feb 18, 2020	SELL	$274.13 - $376.51 $47.2 Million - $64.8 Million	-172,219 Reduced 8.11%	1,952,557 $733 Million
Q3 2019 Nov 14, 2019	BUY	$273.46 - $318.39 $164 Million - $191 Million	599,187 Added 39.28%	2,124,776 $589 Million
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $112 Million - $154 Million	372,238 Added 32.27%	1,525,589 $478 Million
Q1 2019 May 14, 2019	SELL	$372.08 - $439.57 $38.8 Million - $45.9 Million	-104,355 Reduced 8.3%	1,153,351 $474 Million
Q4 2018 Feb 13, 2019	BUY	$335.82 - $403.04 $78.6 Million - $94.4 Million	234,112 Added 22.87%	1,257,706 $470 Million
Q3 2018 Nov 08, 2018	BUY	$351.14 - $408.51 $94.7 Million - $110 Million	269,696 Added 35.77%	1,023,594 $414 Million
Q2 2018 Aug 13, 2018	BUY	$284.6 - $344.99 $152 Million - $184 Million	533,434 Added 241.96%	753,898 $260 Million
Q1 2018 May 14, 2018	SELL	$315.82 - $393.78 $3.37 Million - $4.21 Million	-10,681 Reduced 4.62%	220,464 $75.9 Million
Q4 2017 Feb 13, 2018	BUY	$358.63 - $469.95 $4.06 Million - $5.32 Million	11,324 Added 5.15%	231,145 $86.9 Million
Q3 2017 Nov 13, 2017	BUY	$431.38 - $504.0 $94.8 Million - $111 Million	219,821	219,821 $98.3 Million

Others Institutions Holding REGN

# of Institutions

1,424

Shares Held

82.1M

Call Options Held

835K

Put Options Held

1.46M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $113B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Regeneron Pharmaceuticals, Inc. Transaction History